TY  - JOUR
AU  - Casado-Llombart, Sergi
AU  - Velasco-de Andres, Maria
AU  - Catala, Cristina
AU  - Leyton-Pereira, Alejandra
AU  - Gutierrez-Cozar, Rebeca
AU  - Suarez, Belen
AU  - Armiger, Noelia
AU  - Carreras, Esther
AU  - Esteller, Miriam
AU  - Ricart, Elena
AU  - Ordas, Ingrid
AU  - Gisbert, Javier P
AU  - Chaparro, Maria
AU  - Esteve, Maria
AU  - Marquez, Lucia
AU  - Busquets, David
AU  - Iglesias, Eva
AU  - Garcia-Planella, Esther
AU  - Martin-Arranz, Maria Dolores
AU  - Lohmann, Juliane
AU  - Ayata, C Korcan
AU  - Niess, Jan Hendrik
AU  - Engel, Pablo
AU  - Panes, Julian
AU  - Salas, Azucena
AU  - Domenech, Eugeni
AU  - Lozano, Francisco
PY  - 2022
DO  - 10.3389/fimmu.2022.966184
UR  - http://hdl.handle.net/10668/20591
T2  - Frontiers in immunology
AB  - Crohn's disease (CD) and ulcerative colitis (UC) are inflammatory bowel diseases (IBD) resulting from the interaction of multiple environmental, genetic and immunological factors. CD5 and CD6 are paralogs encoding lymphocyte co-receptors involved in...
LA  - en
PB  - Frontiers Research Foundation
KW  - CD5
KW  - CD6
KW  - Crohn’s disease
KW  - inflammatory bowel disease
KW  - ulcerative colitis
KW  - Animals
KW  - Colitis
KW  - Colitis, Ulcerative
KW  - Crohn Disease
KW  - Dextran Sulfate
KW  - Inflammatory Bowel Diseases
KW  - Mice
TI  - Experimental and genetic evidence for the impact of CD5 and CD6 expression and variation in inflammatory bowel disease.
TY  - research article
VL  - 13
ER  -